<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cardiovascular events</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Aspirin enhances platelet isoprostanes in type 2 diabetes</title>
   	 <description>(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March 16 in Diabetes.</description>
	  <link>http://medicalxpress.com/news/2012-03-aspirin-platelet-isoprostanes-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 23 Mar 2012 14:40:39 EST</pubDate>
	 <guid isPermaLink="false">news251732392</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/aspirinenhan.jpg" width="90" height="90" />
</item>
<item>
     <title>Benefits of Varenicline (Chantix) may balance certain risks</title>
   	 <description>(Medical Xpress) -- The U.S. Food and Drug Administration (FDA) has approved the smoking cessation medication varenicline (Chantix) as an effective aide in helping people quit smoking, including those with cardiovascular disease, although it cautions that varenicline may also be associated with a small, increased risk of certain cardiovascular adverse events in such patients.</description>
	  <link>http://medicalxpress.com/news/2012-03-benefits-varenicline-chantix.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 19 Mar 2012 09:57:27 EST</pubDate>
	 <guid isPermaLink="false">news251369834</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/benefitsofva.jpeg" width="90" height="90" />
</item>
<item>
     <title>Psoriasis patients may face higher heart risk</title>
   	 <description>(HealthDay) -- People with the painful skin condition psoriasis may be at increased risk for health problems that affect the heart, an expert says.</description>
	  <link>http://medicalxpress.com/news/2012-03-psoriasis-patients-higher-heart.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 16 Mar 2012 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news251126906</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/psoriasispat.jpg" width="90" height="90" />
</item>
<item>
     <title>Living kidney donors at no increased risk of heart disease</title>
   	 <description>Living kidney donors are at no greater risk of heart disease than the healthy general population, finds a study published in the British Medical Journal today.</description>
	  <link>http://medicalxpress.com/news/2012-03-kidney-donors-heart-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 02 Mar 2012 04:23:37 EST</pubDate>
	 <guid isPermaLink="false">news249884596</guid>
	 
</item>
<item>
     <title>Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth</title>
   	 <description>Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.</description>
	  <link>http://medicalxpress.com/news/2012-02-treatment-adhd-cardiac-events-youth.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Wed, 08 Feb 2012 10:44:33 EST</pubDate>
	 <guid isPermaLink="false">news247920251</guid>
	 
</item>
<item>
     <title>Study finds air pollution linked to diabetes and hypertension in African-American women</title>
   	 <description>(Boston) -The incidence of type 2 diabetes and hypertension increases with cumulative levels of exposure to nitrogen oxides, according to a new study led by researchers from the Slone Epidemiology Center (SEC) at Boston University. The study, which appears online in the journal Circulation, was led by Patricia Coogan, D.Sc., associate professor of epidemiology at the Boston University School of Public Health and the SEC.</description>
	  <link>http://medicalxpress.com/news/2012-01-air-pollution-linked-diabetes-hypertension.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 05 Jan 2012 14:20:01 EST</pubDate>
	 <guid isPermaLink="false">news244994555</guid>
	 
</item>
<item>
     <title>Bariatric surgery associated with reduction in cardiovascular events and death</title>
   	 <description>Among obese individuals, having bariatric surgery was associated with a reduced long-term incidence of cardiovascular deaths and events such as heart attack and stroke, according to a study in the January 4 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2012-01-bariatric-surgery-reduction-cardiovascular-events.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 03 Jan 2012 16:24:10 EST</pubDate>
	 <guid isPermaLink="false">news244830226</guid>
	 
</item>
<item>
     <title>Analysis does not support genetic test before use of anti-clotting drug</title>
   	 <description>Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2011-12-analysis-genetic-anti-clotting-drug.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 27 Dec 2011 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news244196798</guid>
	 
</item>
<item>
     <title>No increased risk of serious cardiovascular events among adults who use ADHD medications: study</title>
   	 <description>Although there have been cardiovascular safety concerns about attention-deficit/hyperactivity disorder (ADHD) medications because of their ability to increase heart rate and blood pressure levels, an analysis that included more than 150,000 ADHD users found no evidence of an increased risk of heart attack, stroke or sudden cardiac death associated with current use compared with nonuse or rare use among young and middle-aged adults, according to a study appearing in JAMA. The study is being released early online because of its public health importance.</description>
	  <link>http://medicalxpress.com/news/2011-12-cardiovascular-events-adults-adhd-medications.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Mon, 12 Dec 2011 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news242905723</guid>
	 
</item>
<item>
     <title>New study calls sodium intake guidelines into question</title>
   	 <description>For years doctors have warned that too much salt is bad for your heart. Now a new McMaster University study suggests that both high and low levels of salt intake may put people with heart disease or diabetes at increased risk of cardiovascular complications.</description>
	  <link>http://medicalxpress.com/news/2011-11-sodium-intake-guidelines.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 22 Nov 2011 17:05:20 EST</pubDate>
	 <guid isPermaLink="false">news241203899</guid>
	 
</item>
<item>
     <title>Increasing dosage of clopidogrel for patients with genetic variation improves response to medication</title>
   	 <description>Among patients with stable cardiovascular disease who have a genetic variation that diminishes the response to the antiplatelet drug clopidogrel, tripling the standard daily dosage of this medication resulted in improved platelet reactivity, according to a study appearing in JAMA. The study is being released early online to coincide with its presentation at the American Heart Association Scientific Sessions.</description>
	  <link>http://medicalxpress.com/news/2011-11-dosage-clopidogrel-patients-genetic-variation.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 16 Nov 2011 09:15:01 EST</pubDate>
	 <guid isPermaLink="false">news240657289</guid>
	 
</item>
<item>
     <title>Niacin does not reduce heart attack, stroke risk in stable CV patients</title>
   	 <description>In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack and stroke.</description>
	  <link>http://medicalxpress.com/news/2011-11-niacin-heart-stable-cv-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 15 Nov 2011 11:06:17 EST</pubDate>
	 <guid isPermaLink="false">news240576281</guid>
	 
</item>
<item>
     <title>Eliminating co-payments for heart attack medications increases adherence</title>
   	 <description>The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack. The findings will be presented as a Late Breaking Clinical Trial at the American Heart Association Scientific Sessions on November 14 and simultaneously published online in the New England Journal of Medicine.</description>
	  <link>http://medicalxpress.com/news/2011-11-co-payments-heart-medications-adherence.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 14 Nov 2011 11:30:39 EST</pubDate>
	 <guid isPermaLink="false">news240492629</guid>
	 
</item>
<item>
     <title>Abused girls may have higher risk of heart disease, stroke as adults</title>
   	 <description>Sexually and physically abused girls may have higher risks for heart attacks, heart disease and strokes as adults, according to research presented at the American Heart Association's Scientific Sessions 2011.</description>
	  <link>http://medicalxpress.com/news/2011-11-abused-girls-higher-heart-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 13 Nov 2011 12:15:52 EST</pubDate>
	 <guid isPermaLink="false">news240408928</guid>
	 
</item>
<item>
     <title>No heart attack risk from attention-deficit drugs: study</title>
   	 <description> A major study of more than one million children and young adults has shown no higher risk of heart attack among those who take drugs for attention deficit hyperactivity disorder, a US study said Tuesday.</description>
	  <link>http://medicalxpress.com/news/2011-11-heart-attention-deficit-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 01 Nov 2011 10:18:59 EST</pubDate>
	 <guid isPermaLink="false">news239361530</guid>
	 
</item>
<item>
     <title>HPV linked to cardiovascular disease in women</title>
   	 <description>Women with cancer-causing strains of human papillomavirus (HPV) may be at increased risk for cardiovascular disease (CVD) and stroke even when no conventional risk factors for CVD are present.</description>
	  <link>http://medicalxpress.com/news/2011-10-hpv-linked-cardiovascular-disease-women.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 24 Oct 2011 16:31:35 EST</pubDate>
	 <guid isPermaLink="false">news238692570</guid>
	 
</item>
<item>
     <title>New analysis of the cardiovascular risks of common non-steroidal anti-inflammatory drugs</title>
   	 <description>An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen and low dose ibuprofen are least likely to increase cardiovascular risk whereas diclofenac, even in doses available without prescription, elevates risk.</description>
	  <link>http://medicalxpress.com/news/2011-09-analysis-cardiovascular-common-non-steroidal-anti-inflammatory.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 27 Sep 2011 18:21:06 EST</pubDate>
	 <guid isPermaLink="false">news236366456</guid>
	 
</item>
<item>
     <title>Study examines platelet function testing for guiding antithrombotic treatment before PCI procedures</title>
   	 <description>Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity (platelets resistant to antithrombotic therapy) were at an increased risk of an ischemic event at short- and long-term follow-up of up to 2 years, according to a study in the September 21 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2011-09-platelet-function-antithrombotic-treatment-pci.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 20 Sep 2011 17:00:38 EST</pubDate>
	 <guid isPermaLink="false">news235756819</guid>
	 
</item>
<item>
     <title>Body clock found to regulate platelet function</title>
   	 <description>Researchers at Brigham and Women's Hospital (BWH) have demonstrated that the circadian system, the body's internal clock, regulates human platelet function and causes a peak in platelet activation corresponding to the known morning peak in adverse cardiovascular events. These findings are published in PLoS ONE on September 8, 2011.</description>
	  <link>http://medicalxpress.com/news/2011-09-body-clock-platelet-function.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 09 Sep 2011 10:03:23 EST</pubDate>
	 <guid isPermaLink="false">news234781387</guid>
	 
</item>
<item>
     <title>Lower achieved platelet reactivity associated with better cardiovascular</title>
   	 <description>Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent thrombosis, as indicated by a clinical trial presented today at the ESC Congress 2011.</description>
	  <link>http://medicalxpress.com/news/2011-08-platelet-reactivity-cardiovascular.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 30 Aug 2011 11:34:38 EST</pubDate>
	 <guid isPermaLink="false">news233922850</guid>
	 
</item>
<item>
     <title>New study shows patients with coronary artery disease</title>
   	 <description>Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes understanding the risk of complications from orthopedic surgery exceedingly important. However, there is a lack of data investigating the incidence of thrombotic and bleeding complications in orthopedic surgery.</description>
	  <link>http://medicalxpress.com/news/2011-08-patients-coronary-artery-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 30 Aug 2011 11:21:59 EST</pubDate>
	 <guid isPermaLink="false">news233922097</guid>
	 
</item>
<item>
     <title>The Homburg Cream and Sugar study</title>
   	 <description>The Homburg Cream and Sugar (HCS) study was designed to determine whether the measurement of postprandial triglyceride in addition to the assessment of glucose tolerance and traditional risk factors might improve the prediction of cardiovascular events.</description>
	  <link>http://medicalxpress.com/news/2011-08-homburg-cream-sugar.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 29 Aug 2011 11:46:26 EST</pubDate>
	 <guid isPermaLink="false">news233837176</guid>
	 
</item>
<item>
     <title>The number of patients with cardiac problems during pregnancy is increasing</title>
   	 <description>Pre-existing heart disease is rarely a contraindication to pregnancy - indeed, many women with heart disorders tolerate pregnancy well - but it remains a &quot;major concern&quot; that complications are frequent and in some cases may be life-threatening for both the mother and her child. In Europe maternal heart disease has now become the major cause of maternal death during pregnancy.</description>
	  <link>http://medicalxpress.com/news/2011-08-patients-cardiac-problems-pregnancy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 29 Aug 2011 10:03:05 EST</pubDate>
	 <guid isPermaLink="false">news233830824</guid>
	 
</item>
<item>
     <title>It's official -- chocolate linked to heart health</title>
   	 <description>High levels of chocolate consumption might be associated with a one third reduction in the risk of developing heart disease, finds a study published in the British Medical Journal today.</description>
	  <link>http://medicalxpress.com/news/2011-08-chocolate-linked-heart-health.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 29 Aug 2011 08:48:57 EST</pubDate>
	 <guid isPermaLink="false">news233826522</guid>
	 
</item>
<item>
     <title>Certain biologic therapies for psoriasis do not appear to increase risk for cardiovascular problems</title>
   	 <description>Although some preliminary reports have indicated an increased risk of major adverse cardiovascular events with the use of certain biologic therapies to treat chronic plaque psoriasis, an analysis of previous studies finds no significant difference in the rate of these events among patients who received these medications compared to patients who received placebo, according to an article in the August 24/31 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2011-08-biologic-therapies-psoriasis-cardiovascular-problems.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 23 Aug 2011 16:50:36 EST</pubDate>
	 <guid isPermaLink="false">news233336950</guid>
	 
</item>
<item>
     <title>Blood pressure drugs may offer benefits in valvular heart disease</title>
   	 <description>Drugs used to treat blood pressure could offer significant benefits to patients with one of the most common forms of valvular heart disease, new research at the University of Dundee and NHS Tayside has revealed.</description>
	  <link>http://medicalxpress.com/news/2011-08-blood-pressure-drugs-benefits-valvular.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 01 Aug 2011 12:40:06 EST</pubDate>
	 <guid isPermaLink="false">news231417169</guid>
	 
</item>
<item>
     <title>Concern over intensive treatment for patients with type 2 diabetes</title>
   	 <description>Doctors should be cautious about prescribing intensive glucose lowering treatment for patients with type 2 diabetes as a way of reducing heart complications, concludes a new study published in the British Medical Journal today.</description>
	  <link>http://medicalxpress.com/news/2011-07-intensive-treatment-patients-diabetes.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 26 Jul 2011 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news230919315</guid>
	 
</item>
<item>
     <title>Test measuring blood glucose control may help predict risk of CVD events in patients with diabetes</title>
   	 <description>Measuring hemoglobin A 1c (HbA 1c ) levels in patients with diabetes is associated with improvement in models for predicting risk for cardiovascular disease (CVD), according to a report published Online First today by Archives of Internal Medicine.</description>
	  <link>http://medicalxpress.com/news/2011-07-blood-glucose-cvd-events-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 25 Jul 2011 16:52:20 EST</pubDate>
	 <guid isPermaLink="false">news230831515</guid>
	 
</item>
<item>
     <title>Cutting down on salt doesn't reduce your chance of dying</title>
   	 <description>Moderate reductions in the amount of salt people eat doesn't reduce their likelihood of dying or experiencing cardiovascular disease. This is the main conclusion from a systematic review published in the latest edition of The Cochrane Library.</description>
	  <link>http://medicalxpress.com/news/2011-07-salt-doesnt-chance-dying.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 06 Jul 2011 03:12:14 EST</pubDate>
	 <guid isPermaLink="false">news229140725</guid>
	 
</item>
<item>
     <title>Diabetes drug side effects traced to fat action</title>
   	 <description>For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain. Now, two separate studies in the July Cell Metabolism, a Cell Press publication, explore those other effects of the drugs known collectively as  thiazolidinediones (TZDs), both of which stem from their activity in fat.</description>
	  <link>http://medicalxpress.com/news/2011-07-diabetes-drug-side-effects-fat.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 05 Jul 2011 12:29:26 EST</pubDate>
	 <guid isPermaLink="false">news229087751</guid>
	 
</item>


</channel>
</rss>
